[Treatment of metastatic bone pain with Aredia(Pamidronate)].
OBJECTIVE
To evaluate the efficacy of Aredia to relieve pain due to metastatic bone tumor.


METHODS
Aredia 60-90 mg in 500 ml 5% glucose or normal saline was given by i.v. infusion. The treatment was repeated at 2-4 week intervals.


RESULTS
Complete relief of pain was observed in 9 patients, partial relief in 13 patients. The treatment was of no effect in 3 patients. The therapeutic effect was achieved in 72.7% of the patients within 2 weeks.


CONCLUSIONS
Aredia is a good pain reliever in patients with metastatic cancer of the bone.
Jin
M
M
School of Oncology, Beijing Medical University, Beijing Cancer Hospital.
Yang
B
B
Lei
L
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000503:physiopathology / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D000077268:Pamidronate
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004164:Diphosphonates; D000077268:Pamidronate